WWL0245 is a potent and selective BRD4-targeting PROTAC that exhibits sub-nanomolar degradation efficiency (DC50 < 1 nM) for BRD4 over BRD2/3 and PLK1 (DC50 > 1 µM). It demonstrates pronounced selective cytotoxicity in BETi-sensitive cancer cell lines, particularly in AR-positive prostate cancer lines, making it a promising candidate for research in AR-positive prostate cancer and a valuable tool for the investigation of BRD4s biological function [1].
Molecular Weight:
873.96
CAS Number:
[2869057-11-2]
Formula:
C45H51N11O8
Target:
Epigenetic Reader Domain
T79065
* VAT and and shipping costs not included. Errors and price changes excepted
